AMGN — AMGEN INC

—
Nasdaq · Health Care · Biotechnology · CIK 318154 ·
Last close
$414.61
Market Cap
$224.15B
52W High
$447.03
52W Low
$262.49
ADV30
2,833,763
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 10,054,000,000 7,243,000,000 3,514,000,000 2,375,000,000 95,639,000,000 13,989,000,000 83,951,000,000
Mar 2026 8,618,000,000 5,874,000,000 2,666,000,000 1,819,000,000 92,504,000,000 12,038,000,000 83,314,000,000
Dec 2025 9,866,000,000 6,890,000,000 2,720,000,000 1,333,000,000 90,586,000,000 9,129,000,000 81,928,000,000
Sep 2025 9,557,000,000 6,475,000,000 2,526,000,000 3,216,000,000 90,141,000,000 9,445,000,000 80,522,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$10,756,000,000
Investing CF
$-2,212,000,000
Financing CF
$-5,316,000,000
CapEx
$-2,159,000,000
Dividends Paid
$-5,203,000,000
Buybacks
—
EPS Diluted TTM
$14.37
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-22,275,000,000
Inventory
$6,220,000,000
Receivables
$10,227,000,000
ST Investments
—
EBIT TTM
$12,955,000,000
Pretax Income TTM
$10,287,000,000
Interest Exp TTM
$2,668,000,000
Analysts
29

Yahoo Snapshot (yfinance, live)

Total Revenue
$38,094,999,552
EBITDA
$17,268,000,768
Free Cash Flow
$8,645,624,832
Enterprise Value
$247,322,492,928
Total Cash
$13,989,000,192
Total Debt
$57,303,998,464
Shares Out
540,632,005
Trailing EPS
$16.11
Book Value
$21.62
ROE
91.5%
ROA
8.7%
Div Yield
2.64%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 36,751,000,000 9,080,000,000 7,711,000,000 90,586,000,000 81,928,000,000 8,658,000,000 9,958,000,000
Dec 2024 33,424,000,000 7,258,000,000 4,090,000,000 91,839,000,000 85,962,000,000 5,877,000,000 11,490,000,000
Dec 2023 28,190,000,000 7,897,000,000 6,717,000,000 97,154,000,000 90,922,000,000 6,232,000,000 8,471,000,000
Dec 2022 26,323,000,000 9,566,000,000 6,552,000,000 65,121,000,000 61,460,000,000 3,661,000,000 9,721,000,000

TTM Snapshot

Revenues TTM
$30,207,000,000
NetIncome TTM
$8,433,000,000
OpCashFlow TTM
$0
Assets (Latest)
$90,586,000,000
Forward EPS
$24.40

Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $460.00 · spot: $414.61 · call volume: 3,971 · put volume: 27,429
Expected Move to 2026-10-16: ±$21.70 (5.23%) — implied range $392.91 – $436.31 · ATM straddle on $415.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
GILD GILEAD SCIENCES, INC. $187.15B $150.93 —
MRNA Moderna, Inc. $79.40B $198.88 —
ARGX ARGENX SE $59.67B $959.49 —
RVMD Revolution Medicines, Inc. $43.93B $204.97 —
BIIB BIOGEN INC. $33.63B $227.60 —

News headlines (Yahoo Finance, 1h cache)

Why Amgen’s Pipeline Just Got More Interesting
2026-09-27 20:34 · Yahoo
Amgen (AMGN) Sells its Deerfield Campus for $151 Million and Leases it Back
2026-09-27 19:55 · Yahoo
Amgen’s Deerfield office campus sold to Mesirow for $151M in sale-leaseback deal
2026-09-25 22:00 · Yahoo
Amgen (AMGN) Rises Higher Than Market: Key Facts
2026-09-25 20:50 · Yahoo
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
2026-09-25 12:00 · Yahoo
UPLIZNA Market Poised for Growth Through 2034 as Expanding Indications and Rising Demand Drive Sales Opportunities
2026-09-24 08:34 · Yahoo
Amgen (AMGN) Is Up 7.9% After Positive Phase 3 Dazodalibep Data in Systemic Sjögren’s Disease
2026-09-24 01:14 · Yahoo
AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study
2026-09-23 14:38 · Yahoo
2 Healthcare Stocks That Just Delivered Great News for Investors
2026-09-26 20:21 · Yahoo
Keystone To Launch India Business With Bengaluru As First Hub, Plans To Hire Talent & Increase Workforce Over Next Two Years
2026-09-25 14:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.